What are Synthetic cannabinoid drugs?

Synthetic cannabinoid drugs are pharmacologic agents that share a common mechanism (typically targeting CB1 and CB2 cannabinoid receptors). 2 are currently marketed, with 2 more in clinical development.

What are the marketed Synthetic cannabinoid drugs?

Marketed Synthetic cannabinoid drugs include Cesamet™ (nabilone), Nabilone Oral Capsule.

Synthetic cannabinoid

2 marketed 2 in Phase 3

This page covers all Synthetic cannabinoid drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting CB1 and CB2 cannabinoid receptors, CB1 receptor, CB2 receptor.

Targets

CB1 and CB2 cannabinoid receptors · CB1 receptor, CB2 receptor

Marketed (2)

Cesamet™ (nabilone) · NEMA Research, Inc. · Oncology, Anesthesia
Nabilone is a synthetic cannabinoid that mimics THC and binds to cannabinoid receptors in the central nervous system to reduce nausea and vomiting.
Nabilone Oral Capsule · Centre for Addiction and Mental Health · Oncology; Pain Management; Psychiatry
Nabilone is a synthetic cannabinoid that mimics THC by binding to cannabinoid receptors in the central nervous system to produce antiemetic and analgesic effects.

Phase 3 pipeline (2)

Nabilone Capsules · Eldon Loh, MD · Oncology, Gastroenterology
Nabilone is a synthetic cannabinoid that mimics THC and activates cannabinoid receptors in the central nervous system to reduce nausea and vomiting.
Nabilone, flexible dosing · University of Calgary · Pain management, Oncology (chemotherapy-induced nausea and vomiting)
Nabilone is a synthetic cannabinoid that mimics THC and activates cannabinoid receptors in the central nervous system to modulate pain, nausea, and other symptoms.